FILE PHOTO: 3D-printed toy figurines, a syringe and a vial labelled "coronavirus disease (COVID-19) vaccine" are seen in front of India flag in this illustration taken May 4, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
NEW DELHI (Reuters) - India's rising output of COVID-19 vaccines and the inoculation of more than half its adult population with at least one dose are raising hopes the country will return as an exporter within months, ramping up from early next year.
After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on domestic immunisation as infections exploded, upsetting the inoculation plans of many African https://www.reuters.com/business/healthcare-pharmaceuticals/indias-halt-vaccine-exports-very-problematic-africa-2021-05-18 and South Asian countries https://www.reuters.com/world/india/nepal-bangladesh-scramble-secure-covid-19-shots-india-curbs-exports-2021-05-19.
